CONMED Book Value Per Share from 2010 to 2025

CNMD Stock

USD 58.85 1.50 2.49%

CONMED's Book Value Per Share is increasing over the years with slightly volatile fluctuation. Overall, Book Value Per Share is expected to go to 32.77 this year. Book Value Per Share is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of CONMED according to its financial statements. View All Fundamentals

Book Value Per Share

First Reported

2010-12-31

Previous Quarter

31.20926538

Current Value

32.77

Quarterly Volatility

6.43770664

Credit Downgrade

Yuan Drop

Covid

Check CONMED financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CONMED's main balance sheet or income statement drivers, such as Depreciation And Amortization of 75.4 M, Interest Expense of 39.2 M or Selling General Administrative of 210 M, as well as many indicators such as Price To Sales Ratio of 0.98, Dividend Yield of 0.0135 or PTB Ratio of 1.3. CONMED financial statements analysis is a perfect complement when working with CONMED Valuation or Volatility modules.

Check out the analysis of CONMED Correlation against competitors.

For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.

Latest CONMED's Book Value Per Share Growth Pattern

Below is the plot of the Book Value Per Share of CONMED over the last few years. It is the ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements. CONMED's Book Value Per Share historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CONMED's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 31.15 X

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Book Value Per Share

Timeline

CONMED Book Value Per Share Regression Statistics

	Arithmetic Mean	23.06
	Geometric Mean	21.27
	Coefficient Of Variation	27.91
	Mean Deviation	3.98
	Median	23.55
	Standard Deviation	6.44
	Sample Variance	41.44
	Range	29.5758
	R-Value	0.81
	Mean Square Error	15.08
	R-Squared	0.66
	Significance	0.0001
	Slope	1.10
	Total Sum of Squares	621.66

CONMED Book Value Per Share History

	2025	32.77
	2024	31.21
	2023	27.2
	2022	24.82
	2021	26.93
	2020	24.81
	2019	25.08

Other Fundumenentals of CONMED

Tangible Book Value Per Share

CONMED Book Value Per Share component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Net Receivables	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Accounts Payable	Good Will	Common Stock	Long Term Debt	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Deferred Long Term Liab	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.93	0.95	0.83	0.95	0.98	0.95	0.19	0.87	0.95	0.9	-0.41	0.86	0.32	0.33	0.07	-0.93	0.94	0.83	-0.67	0.35	0.87	0.77	-0.5
Total Stockholder Equity	0.93		0.77	0.96	0.98	0.84	0.96	0.07	0.73	0.87	0.74	-0.19	0.64	0.09	0.59	-0.03	-0.73	0.79	0.68	-0.51	0.12	0.68	0.66	-0.55
Net Debt	0.95	0.77		0.65	0.83	0.98	0.81	0.25	0.87	0.92	0.93	-0.61	0.97	0.48	0.03	0.24	-0.99	0.97	0.87	-0.79	0.46	0.91	0.76	-0.43
Retained Earnings	0.83	0.96	0.65		0.92	0.72	0.86	0.0	0.68	0.76	0.63	-0.17	0.5	-0.16	0.65	0.1	-0.6	0.66	0.53	-0.38	0.08	0.49	0.48	-0.46
Net Receivables	0.95	0.98	0.83	0.92		0.89	0.94	0.09	0.8	0.91	0.8	-0.29	0.72	0.14	0.5	0.02	-0.8	0.84	0.72	-0.58	0.16	0.73	0.68	-0.5
Total Liab	0.98	0.84	0.98	0.72	0.89		0.89	0.24	0.89	0.93	0.93	-0.5	0.93	0.42	0.18	0.11	-0.97	0.96	0.85	-0.71	0.44	0.91	0.78	-0.45
Total Current Assets	0.95	0.96	0.81	0.86	0.94	0.89		0.15	0.75	0.9	0.77	-0.21	0.7	0.24	0.53	-0.15	-0.8	0.83	0.74	-0.51	0.21	0.79	0.77	-0.56
Short Term Debt	0.19	0.07	0.25	0.0	0.09	0.24	0.15		0.3	0.04	0.31	0.01	0.15	0.09	0.04	0.08	-0.21	0.1	0.13	-0.31	0.76	0.2	0.04	0.25
Intangible Assets	0.87	0.73	0.87	0.68	0.8	0.89	0.75	0.3		0.76	0.96	-0.48	0.79	0.14	0.19	0.26	-0.87	0.8	0.78	-0.62	0.51	0.76	0.64	-0.07
Accounts Payable	0.95	0.87	0.92	0.76	0.91	0.93	0.9	0.04	0.76		0.82	-0.52	0.89	0.47	0.2	0.05	-0.92	0.97	0.86	-0.69	0.2	0.88	0.86	-0.67
Good Will	0.9	0.74	0.93	0.63	0.8	0.93	0.77	0.31	0.96	0.82		-0.51	0.88	0.38	0.1	0.24	-0.92	0.87	0.9	-0.77	0.48	0.89	0.77	-0.18
Common Stock	-0.41	-0.19	-0.61	-0.17	-0.29	-0.5	-0.21	0.01	-0.48	-0.52	-0.51		-0.7	-0.38	0.56	-0.71	0.63	-0.61	-0.5	0.56	-0.32	-0.47	-0.38	0.2
Long Term Debt	0.86	0.64	0.97	0.5	0.72	0.93	0.7	0.15	0.79	0.89	0.88	-0.7		0.61	-0.16	0.25	-0.98	0.97	0.87	-0.8	0.42	0.93	0.78	-0.46
Treasury Stock	0.32	0.09	0.48	-0.16	0.14	0.42	0.24	0.09	0.14	0.47	0.38	-0.38	0.61		-0.48	-0.15	-0.52	0.53	0.62	-0.6	0.16	0.69	0.69	-0.44
Property Plant Equipment	0.33	0.59	0.03	0.65	0.5	0.18	0.53	0.04	0.19	0.2	0.1	0.56	-0.16	-0.48		-0.47	0.0	0.05	0.01	0.25	-0.16	0.01	0.08	-0.2
Current Deferred Revenue	0.07	-0.03	0.24	0.1	0.02	0.11	-0.15	0.08	0.26	0.05	0.24	-0.71	0.25	-0.15	-0.47		-0.17	0.15	0.09	-0.32	0.3	-0.01	-0.17	0.26
Net Tangible Assets	-0.93	-0.73	-0.99	-0.6	-0.8	-0.97	-0.8	-0.21	-0.87	-0.92	-0.92	0.63	-0.98	-0.52	0.0	-0.17		-0.98	-0.88	0.76	-0.43	-0.93	-0.81	0.45
Long Term Debt Total	0.94	0.79	0.97	0.66	0.84	0.96	0.83	0.1	0.8	0.97	0.87	-0.61	0.97	0.53	0.05	0.15	-0.98		0.89	-0.76	0.32	0.93	0.83	-0.6
Capital Surpluse	0.83	0.68	0.87	0.53	0.72	0.85	0.74	0.13	0.78	0.86	0.9	-0.5	0.87	0.62	0.01	0.09	-0.88	0.89		-0.8	0.28	0.95	0.93	-0.42
Deferred Long Term Liab	-0.67	-0.51	-0.79	-0.38	-0.58	-0.71	-0.51	-0.31	-0.62	-0.69	-0.77	0.56	-0.8	-0.6	0.25	-0.32	0.76	-0.76	-0.8		-0.37	-0.78	-0.66	0.31
Short Long Term Debt	0.35	0.12	0.46	0.08	0.16	0.44	0.21	0.76	0.51	0.2	0.48	-0.32	0.42	0.16	-0.16	0.3	-0.43	0.32	0.28	-0.37		0.34	0.14	0.21
Net Invested Capital	0.87	0.68	0.91	0.49	0.73	0.91	0.79	0.2	0.76	0.88	0.89	-0.47	0.93	0.69	0.01	-0.01	-0.93	0.93	0.95	-0.78	0.34		0.91	-0.48
Net Working Capital	0.77	0.66	0.76	0.48	0.68	0.78	0.77	0.04	0.64	0.86	0.77	-0.38	0.78	0.69	0.08	-0.17	-0.81	0.83	0.93	-0.66	0.14	0.91		-0.56
Capital Stock	-0.5	-0.55	-0.43	-0.46	-0.5	-0.45	-0.56	0.25	-0.07	-0.67	-0.18	0.2	-0.46	-0.44	-0.2	0.26	0.45	-0.6	-0.42	0.31	0.21	-0.48	-0.56

Click cells to compare fundamentals

About CONMED Financial Statements

CONMED stakeholders use historical fundamental indicators, such as CONMED's Book Value Per Share, to determine how well the company is positioned to perform in the future. Although CONMED investors may analyze each financial statement separately, they are all interrelated. For example, changes in CONMED's assets and liabilities are reflected in the revenues and expenses on CONMED's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in CONMED. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Book Value Per Share	31.21	32.77
Tangible Book Value Per Share	(14.92)	(14.18)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether CONMED is a strong investment it is important to analyze CONMED's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CONMED's future performance. For an informed investment choice regarding CONMED Stock, refer to the following important reports:

How To Invest In CONMED

Details

Is CONMED Stock a good investment?

Details

What is CONMED's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out the analysis of CONMED Correlation against competitors.

For information on how to trade CONMED Stock refer to our How to Trade CONMED Stock guide.

You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CONMED. If investors know CONMED will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CONMED listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.028

Dividend Share

0.8

Earnings Share

4.25

Revenue Per Share

42.372

Quarterly Revenue Growth

0.058

The market value of CONMED is measured differently than its book value, which is the value of CONMED that is recorded on the company's balance sheet. Investors also form their own opinion of CONMED's value that differs from its market value or its book value, called intrinsic value, which is CONMED's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CONMED's market value can be influenced by many factors that don't directly affect CONMED's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between CONMED's value and its price as these two are different measures arrived at by different means. Investors typically determine if CONMED is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CONMED's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

CONMED Book Value Per Share from 2010 to 2025

Latest CONMED's Book Value Per Share Growth Pattern

CONMED Book Value Per Share Regression Statistics

CONMED Book Value Per Share History

Other Fundumenentals of CONMED

CONMED Book Value Per Share component correlations

About CONMED Financial Statements

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY